FindTrial
Sign In

Can a a policy of reducing blood loses and iron and vitamin supplimentation decease the need of blood transfusion in preterm neonates

The effectiveness of anemia prevention bundle in reducing the transfusion rates in preterm neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019864
Enrollment
60
Registered
2019-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P612- Anemia of prematurity

Interventions

Intervention1: Anemia prevention bundle: Base rate of transfusion are assessed,anemia prevention bundle is applied ( consists of judicious use of investigation , clubbing of investigation and use of i

Sponsors

Dr Sreekanth R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All preterm babies < 32 weeks admitted to NICU at birth

Exclusion criteria

Exclusion criteria: 1.Neonates more than 32 weeks of gestational age 2.Newborn with congenital anomalies or genetic disorders 3.All babies with suspected/proven etiologies of anemia like hemolytic anemia 4.Neonates with pulmonary hemorrhage and grade 3 or 4 intraventricular hemorrhage 5.Parents refuse to consent

Design outcomes

Primary

MeasureTime frame
To estimate reduction in mean number of blood transfusions following implementation of anaemia prevention bundleTimepoint: AT 37 WEEKS OF CORRECETD GESTATIONAL AGE—

Secondary

MeasureTime frame
To estimate the mean hemoglobin and hematocrit in preterm newborns before and after implementation of anaemia prevention bundle.Timepoint: AT 37 WEEKS OF CORRECTED GESTATIONAL AGE—

Countries

India

Contacts

Public ContactDr Sreekanth R

Mehtas hospitals

drlakshmi2008@gmail.com9840211742

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026